KBR Aug 03, 2023
The Korean Advanced Institute of Science and Technology KAIST said Thursday that its researchers developed a nano-composite that simultaneously delivers CRISPR proteins and drugs in vivo with superior anticancer efficacy compared to existing therapies.CRISPR technology precisely and permanently ca